{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:34:23Z","timestamp":1789684463085,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although hypercalcemia is a risk factor for all-cause mortality in hemodialysis patients, it remains unknown whether hypercalcemia increases the risk of infection-related death. A total of 2869 hemodialysis patients registered in the Q-Cohort Study, a multicenter, prospective cohort study of hemodialysis patients, were analyzed. The predictor was albumin-corrected serum calcium level at baseline. The main outcome was infection-related death. Death risk were estimated by multivariable-adjusted Cox proportional hazard risk models and competing risk models. During the follow-up period of 4 years, 107 patients died of infection and 473 died of any cause. The patients were divided into four groups by the serum calcium level at baseline (G1, 5.7\u20138.9\u2009mg\/dL; G2, 9.0\u20139.4\u2009mg\/dL; G3, 9.5\u20139.9\u2009mg\/L; G4 10.0\u201316.5\u2009mg\/dL). In the multivariable-adjusted model, the incidence of infection-related death was significantly higher in the highest serum calcium group (G4) compared with the lowest serum calcium group (G1): hazard ratio [95% confidence interval], 2.34 [1.35\u20134.04], <jats:italic>P<\/jats:italic>\u2009=\u20090.002. Furthermore, higher serum calcium level was significantly associated with increased risk of all-cause death. In conclusion, our data suggest that a higher serum calcium level may be a risk factor for infection-related and all-cause death in hemodialysis patients.<\/jats:p>","DOI":"10.1038\/s41598-020-63334-8","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:03:12Z","timestamp":1586858592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased Risk of Infection-Related and All-Cause Death in Hypercalcemic Patients Receiving Hemodialysis: The Q-Cohort Study"],"prefix":"10.1038","volume":"10","author":[{"given":"Shunsuke","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hokuto","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tokumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"63334_CR1","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113, S1\u2013S130 (2009)."},{"key":"63334_CR2","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","volume":"27","author":"MC Hu","year":"2012","unstructured":"Hu, M. C., Kuro-o, M. & Moe, O. W. The emerging role of Klotho in clinical nephrology. Nephrol. Dial. Transpl. 27, 2650\u20132657 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"63334_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. & Port, F. K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 31, 607\u2013617 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"63334_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1744-9987.12030","volume":"17","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi, M. et al. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther. Apher. Dial. 17, 221\u2013228 (2013).","journal-title":"Ther. Apher. Dial."},{"key":"63334_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","volume":"100","author":"S Yamada","year":"2017","unstructured":"Yamada, S. & Giachelli, C. M. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone 100, 87\u201393 (2017).","journal-title":"Bone"},{"key":"63334_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1755-6686.2013.12009.x","volume":"39","author":"SP Chennasamudram","year":"2013","unstructured":"Chennasamudram, S. P., Noor, T. & Vasylyeva, T. L. Comparison of sevelamer and calcium carbonate on endothelial function and inflammation in patients on peritoneal dialysis. J. Ren. Care 39, 82\u201389 (2013).","journal-title":"J. Ren. Care"},{"key":"63334_CR7","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","volume":"68","author":"GA Block","year":"2005","unstructured":"Block, G. A. et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 68, 1815\u20131824 (2005).","journal-title":"Kidney Int."},{"key":"63334_CR8","unstructured":"US Renal Data System. USRDS 2015 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015."},{"key":"63334_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.ajkd.2010.04.016","volume":"56","author":"LS Dalrymple","year":"2010","unstructured":"Dalrymple, L. S. et al. Infection-related hospitalizations in older patients with ESRD. Am. J. Kidney Dis. 56, 522\u2013530 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"63334_CR10","doi-asserted-by":"publisher","first-page":"e0157361","DOI":"10.1371\/journal.pone.0157361","volume":"11","author":"SD Hwang","year":"2016","unstructured":"Hwang, S. D. et al. Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients. PLoS One 11, e0157361 (2016).","journal-title":"PLoS One"},{"key":"63334_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000168284","volume":"11","author":"JM Alexiewicz","year":"1991","unstructured":"Alexiewicz, J. M., Smogorzewski, M., Fadda, G. Z. & Massry, S. G. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am. J. Nephrol. 11, 102\u2013111 (1991).","journal-title":"Am. J. Nephrol."},{"key":"63334_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1172\/JCI83470","volume":"126","author":"J Rossaint","year":"2016","unstructured":"Rossaint, J. et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J. Clin. Invest. 126, 962\u2013974 (2016).","journal-title":"J. Clin. Invest."},{"key":"63334_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1681\/ASN.2016040401","volume":"28","author":"KL Nowak","year":"2017","unstructured":"Nowak, K. L. et al. Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults. J. Am. Soc. Nephrol. 28, 1239\u20131246 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63334_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2018.06.001","volume":"275","author":"H Arase","year":"2018","unstructured":"Arase, H. et al. Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study. Atherosclerosis 275, 115\u2013123 (2018).","journal-title":"Atherosclerosis"},{"key":"63334_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/ndt\/gfw205","volume":"31","author":"S Tanaka","year":"2016","unstructured":"Tanaka, S. et al. Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study. Nephrol. Dial. Transpl. 31, 1152\u20131160 (2016).","journal-title":"Nephrol. Dial. Transpl."},{"key":"63334_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.ajkd.2017.01.052","volume":"70","author":"S Yamada","year":"2017","unstructured":"Yamada, S. et al. Modified Creatinine Index and the Risk of Bone Fracture in Patients Undergoing Hemodialysis: The Q-Cohort Study. Am. J. Kidney Dis. 70, 270\u2013280 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"63334_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne, R. B., Little, A. J., Williams, R. B. & Milner, J. R. Interpretation of serum calcium in patients with abnormal serum proteins. Br. Med. J. 4, 643\u2013646 (1973).","journal-title":"Br. Med. J."},{"issue":"Suppl 1","key":"63334_CR18","first-page":"S44","volume":"11","author":"J Kazama","year":"2017","unstructured":"Kazama, J. J. Japanese Soc. Dialysis Ther. Treat. Guidel. secondary hyperparathyroidism. Ther Apher. Dial. 11(Suppl 1), S44\u2013S47 (2017).","journal-title":"J. Japanese Soc. Dialysis Ther. Treat. Guidel. secondary hyperparathyroidism. Ther Apher. Dial."},{"key":"63334_CR19","first-page":"8703172","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Risk Factors for Sepsis Based on Sepsis-3 Criteria after Orthotopic Liver Transplantation. Mediators Inflam. 2018, 8703172 (2018).","journal-title":"Mediators Inflam."},{"key":"63334_CR20","doi-asserted-by":"publisher","first-page":"E2465","DOI":"10.3390\/ijms19092465","volume":"19","author":"JA D\u2019Elia","year":"2018","unstructured":"D\u2019Elia, J. A. & Weinrauch, L. A. Roles in Infection and Sepsis Mechanisms of Calcium Channel Blocker Benefits in Immunocompromised Patients at Risk for Infection. Int. J. Mol. Sci. 19, E2465 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"63334_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molimm.2014.10.018","volume":"64","author":"QY Wu","year":"2015","unstructured":"Wu, Q. Y. et al. Activation of calcium-sensing receptor increases TRPC3\/6 expression in T lymphocyte in sepsis. Mol. Immunol. 64, 18\u201325 (2015).","journal-title":"Mol. Immunol."},{"key":"63334_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3109\/10641969309041646","volume":"15","author":"J Li","year":"1993","unstructured":"Li, J., Ehrenfried, L. K. & Bukoski, R. D. Changes in extracellular Ca2+ over a physiologic concentration range differentially modulate reactivity of resistance arteries of spontaneously hypertensive and normotensive rats. Clin. Exp. Hypertens. 15, 849\u2013866 (1993).","journal-title":"Clin. Exp. Hypertens."},{"key":"63334_CR23","first-page":"F317","volume":"246","author":"JE Benabe","year":"1984","unstructured":"Benabe, J. E. et al. Critical role of extracellular calcium in vanadate-induced renal vasoconstriction. Am. J. Physiol. 246, F317\u2013F322 (1984).","journal-title":"Am. J. Physiol."},{"key":"63334_CR24","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1097\/01.hjh.0000186831.41125.51","volume":"23","author":"A Scholze","year":"2005","unstructured":"Scholze, A. et al. Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans. J. Hypertens. 23, 2049\u20132054 (2005).","journal-title":"J. Hypertens."},{"key":"63334_CR25","first-page":"II89","volume":"8","author":"C van Breemen","year":"1986","unstructured":"van Breemen, C., Leijten, P., Yamamoto, H., Aaronson, P. & Cauvin, C. Calcium activation of vascular smooth muscle. State art. lecture. Hypertension 8, II89\u201395 (1986).","journal-title":"State art. lecture. Hypertension"},{"key":"63334_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00223-014-9861-8","volume":"95","author":"E Gravesen","year":"2014","unstructured":"Gravesen, E., Mace, M. L., Hofman-Bang, J., Olgaard, K. & Lewin, E. Circulating FGF23 levels in response to acute changes in plasma Ca(2+). Calcif. Tissue Int. 95, 46\u201353 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"63334_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00223-018-0440-2","volume":"103","author":"Y Shikida","year":"2018","unstructured":"Shikida, Y. et al. Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats. Calcif. Tissue Int. 103, 455\u2013464 (2018).","journal-title":"Calcif. Tissue Int."},{"key":"63334_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh, S. et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 90, 985\u2013996 (2016).","journal-title":"Kidney Int."},{"key":"63334_CR29","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/CIRCRESAHA.110.234260","volume":"108","author":"W Jahnen-Dechent","year":"2011","unstructured":"Jahnen-Dechent, W., Heiss, A., Sch\u00e4fer, C. & Ketteler, M. Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 108, 1494\u20131509 (2011).","journal-title":"Circ. Res."},{"key":"63334_CR30","first-page":"1","volume":"34","author":"M Kuro-o","year":"2014","unstructured":"Kuro-o, M. Calciprotein particle (CPP): a true culprit of phosphorus woes? Nefrologia 34, 1\u20134 (2014).","journal-title":"Nefrologia"},{"key":"63334_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013060635","volume":"25","author":"ER Smith","year":"2014","unstructured":"Smith, E. R. et al. Serum calcification propensity predicts all-cause mortality in predialysis CKD. J. Am. Soc. Nephrol. 25, 339\u2013348 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63334_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19677-4","volume":"8","author":"Y Miura","year":"2018","unstructured":"Miura, Y. et al. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci. Rep. 8, 1256 (2018).","journal-title":"Sci. Rep."},{"key":"63334_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2010.390","volume":"79","author":"AP Sage","year":"2001","unstructured":"Sage, A. P., Lu, J., Tintut, Y. & Demer, L. L. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 79, 414\u2013422 (2001).","journal-title":"Kidney Int."},{"key":"63334_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/01.RES.0000171451.88616.c2","volume":"96","author":"I Nadra","year":"2005","unstructured":"Nadra, I. et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res. 96, 1248\u20131256 (2005).","journal-title":"Circ. Res."},{"key":"63334_CR35","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","volume":"186","author":"B Paz\u00e1r","year":"2011","unstructured":"Paz\u00e1r, B. et al. Basic calcium phosphate crystals induce monocyte\/macrophage IL-1\u03b2 secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186, 2495\u20132502 (2011).","journal-title":"J. Immunol."},{"key":"63334_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nut.2019.03.002","volume":"65","author":"J Rodrigues","year":"2019","unstructured":"Rodrigues, J. et al. Nutritional status of older patients on hemodialysis: Which nutritional markers can best predict clinical outcomes? Nutrition 65, 113\u2013119 (2019).","journal-title":"Nutrition"},{"issue":"Suppl 1","key":"63334_CR37","first-page":"12","volume":"23","author":"P Klemmer","year":"2005","unstructured":"Klemmer, P. J. Calcium loading, calcium accumulation, associated cardiovascular risks dialysis patients. Blood Purif. 23(Suppl 1), 12\u201319 (2005).","journal-title":"J. Calcium loading, calcium accumulation, associated cardiovascular risks dialysis patients. Blood Purif."},{"key":"63334_CR38","first-page":"71","volume":"3","author":"F Assadi","year":"2009","unstructured":"Assadi, F. Hypercalcemia: an evidence-based approach to clinical cases. Iran. J. Kidney Dis. 3, 71\u201379 (2009).","journal-title":"Iran. J. Kidney Dis."},{"key":"63334_CR39","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/j.1523-1755.2004.66015.x","volume":"66","author":"H Yang","year":"2004","unstructured":"Yang, H., Curinga, G. & Giachelli, C. M. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 66, 2293\u20132299 (2004).","journal-title":"Kidney Int."},{"key":"63334_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.2009.481","volume":"77","author":"NK Chen","year":"2010","unstructured":"Chen, N. K. et al. Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int. 77, 436\u2013442 (2010).","journal-title":"Kidney Int."},{"key":"63334_CR41","doi-asserted-by":"publisher","first-page":"F599","DOI":"10.1152\/ajprenal.00303.2006","volume":"292","author":"NX Chen","year":"2007","unstructured":"Chen, N. X., Kircelli, F., O\u2019Neill, K. D., Chen, X. & Moe, S. M. Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am. J. Physiol. Ren. Physiol 292, F599\u2013F606 (2007).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"63334_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3747\/pdi.2017.00163","volume":"38","author":"MMX Cai","year":"2018","unstructured":"Cai, M. M. X. et al. Calciprotein Particle Formation in Peritoneal Dialysis Effluent Is Dependent on Dialysate Calcium Concentration. Perit. Dial. Int. 38, 286\u2013292 (2018).","journal-title":"Perit. Dial. Int."},{"key":"63334_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1517\/14740338.2014.937423","volume":"13","author":"S Genovesi","year":"2014","unstructured":"Genovesi, S. & Gallieni, M. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks? Expert. Opin. Drug. Saf. 13, 1143\u20131148 (2014).","journal-title":"Expert. Opin. Drug. Saf."},{"key":"63334_CR44","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C. et al. FGF23 induces left ventricular hypertrophy. J. Clin. Invest. 121, 4393\u20134408 (2011).","journal-title":"J. Clin. Invest."},{"key":"63334_CR45","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1210\/jc.2016-1369","volume":"101","author":"Y Obi","year":"2016","unstructured":"Obi, Y. et al. Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients. J. Clin. Endocrinol. Metab. 101, 2440\u20132449 (2016).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63334-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63334-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63334-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:14:40Z","timestamp":1670318080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63334-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63334"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63334-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"16 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6327"}}